Release Date: 15/08/18 16:20 Summary: Full Year Statutory Accounts Price Sensitive: No Download Document 4.01MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%